Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial.

ABSTRACT:

Objectives

Our objective was to determine whether early detection of undiagnosed PsA in a primary care psoriasis population improves outcome in physical function at 24 months post-registration.

Methods

A multicentre, prospective, parallel group cluster randomized controlled trial in patients with psoriasis was conducted. Participants with suspected inflammatory arthritis on screening were referred for an assessment of PsA [enhanced surveillance (ES) arm: at baseline, and 12 and 24 months; standard care (SC) arm: at 24 months]. The primary outcome measure was the HAQ Disability Index (HAQ-DI) at 24 months post-registration in participants diagnosed with PsA.

Results

A total of 2225 participants across 135 general practitioner practices registered: 1123 allocated to ES

SUBMITTER: McHugh N 

PROVIDER: S-EPMC11962868 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature